Portfolio (Quarterly)
Guide ↗
Bellevue Group AG
· CIK 0001674546| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 101 | BBNX | BETA BIONICS INC | Healthcare | 72,152.0 | $723K | 0.02% | — | — | $10.02 | +5.9% |
| 102 | BIIB | BIOGEN INC | Healthcare | 3,653.0 | $670K | 0.02% | +88.0 | +2.5% | $183.33 | +3.3% |
| 103 | LEGN | LEGEND BIOTECH CORP | Healthcare | 35,886.0 | $649K | 0.01% | -28K | -43.9% | $18.09 | +54.7% |
| 104 | CSCO | CISCO SYS INC | Technology | 8,000.0 | $621K | 0.01% | — | — | $77.59 | +52.3% |
| 105 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 4,646.0 | $612K | 0.01% | -1.7M | -99.7% | $131.74 | +18.0% |
| 106 | BABA | ALIBABA GROUP HLDG LTD | Consumer Cyclical | 4,700.0 | $590K | 0.01% | — | — | $125.46 | +4.8% |
| 107 | CYTK | CYTOKINETICS INC | Healthcare | 8,841.0 | $583K | 0.01% | -384.0 | -4.2% | $65.91 | +18.4% |
| 108 | CERT | CERTARA INC | Healthcare | 99,442.0 | $567K | 0.01% | — | — | $5.70 | -9.3% |
| 109 | — | PRAXIS PRECISION MEDICINES I | — | 1,757.0 | $566K | 0.01% | NEW | — | $322.19 | — |
| 110 | PG | PROCTER & GAMBLE CO | Consumer Defensive | 3,900.0 | $563K | 0.01% | — | — | $144.44 | -1.4% |
| 111 | MA | MASTERCARD INCORPORATED | Financial Services | 1,100.0 | $550K | 0.01% | — | — | $499.66 | -0.0% |
| 112 | — | CENCORA INC | — | 1,716.0 | $539K | 0.01% | +1K | +229.4% | $314.14 | — |
| 113 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 3,181.0 | $538K | 0.01% | -24K | -88.5% | $169.02 | +38.2% |
| 114 | GDX | VANECK ETF TRUST | — | 5,750.0 | $528K | 0.01% | -10K | -62.9% | $91.77 | -6.2% |
| 115 | AGMB | AGOMAB THERAPEUTICS NV | Healthcare | 50,000.0 | $524K | 0.01% | NEW | — | $10.49 | +4.3% |
| 116 | BLK | BLACKROCK INC | Financial Services | 450.0 | $433K | 0.01% | — | — | $961.71 | +10.6% |
| 117 | V | VISA INC | Financial Services | 1,400.0 | $423K | 0.01% | — | — | $302.24 | +9.4% |
| 118 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 9,030.0 | $359K | 0.01% | NEW | — | $39.72 | +0.2% |
| 119 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 17,766.0 | $341K | 0.01% | +11K | +148.9% | $19.20 | +0.5% |
| 120 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 6,803.0 | $328K | 0.01% | -138K | -95.3% | $48.20 | -19.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.2%
Energy
0.1%
Financial Services
0.1%
Consumer Cyclical
0.0%
Communication Services
0.0%
Consumer Defensive
0.0%